awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37767703-1D89530E-3B2D-4C18-8EC2-02C7B79E0614
Q37767703-1D89530E-3B2D-4C18-8EC2-02C7B79E0614
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37767703-1D89530E-3B2D-4C18-8EC2-02C7B79E0614
New angles of attack in the fight against chronic lymphocytic leukemia: the advent of novel non-chemotherapeutic agents.
P2860
Q37767703-1D89530E-3B2D-4C18-8EC2-02C7B79E0614
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37767703-1D89530E-3B2D-4C18-8EC2-02C7B79E0614
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
db826e6838e6f9fbabb415027183b662cf72f9ee
P2860
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).